Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
5
×
life sciences
national blog main
startups
5
×
boston
clinical trials
national top stories
deals
new york blog main
cancer
chronic rhinosinusitis
decibel therapeutics
fda
flagship pioneering
glaxosmithkline
investing
ipo
laurence reid
lyra therapeutics
new york top stories
renaissance capital
san francisco blog main
san francisco top stories
sanofi
steven holtzman
480 biomedical
abbvie
acceleron pharma
acid sphingomyelinase deficiency
adeno-associated virus
allergan
allosteric
alzheimer's disease
anika therapeutics
annovis bio
arcutis biotherapeutics
arsenal medical
atlas venture
What
therapeutics
5
×
medicines
new
ago
biotech
debut
developing
drugs
years
adding
address
adds
aiming
aims
allosteric
approach
balance
based
bio
black
build
called
clinic
companies
company
continue
debuts
decibel
diamond
diamond’s
disease
elusive
emerged
epigenetic
epigenetics
field
flagship’s
focus
forms
hearing
Language
unset
Current search:
therapeutics
×
startups
×
" boston top stories "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further